Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells.
- Resource Type
- Article
- Source
- Journal of Medicinal Chemistry; 10/27/2022, Vol. 65 Issue 20, p14032-14048, 17p
- Subject
- Language
- ISSN
- 00222623